The observational study of the practical application and clinical utility of cancer genomic profiling tests

The observational study of the practical application and clinical utility of cancer genomic profiling tests - The observational study of the practical application and clinical utility of cancer genomic profiling tests

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049415

Enrollment

1900

Registered

2022-11-02

Start date

2020-06-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undertake or consider the comprehensive profiling tests covered by the national insurance system after June 1, 2019. Patients registered in national and international cancer-related databases will also be included in order to compare the information with treatment and genomic alterations in national and international cancer-related databases.

Exclusion criteria

Exclusion criteria: Patients who have not undergone comprehensive profiling tests covered by the national insurance system.

Design outcomes

Primary

Measure	Time frame
Practical application of comprehensive genomic profiling tests covered by national insurance in clinical practice	—

Secondary

Measure	Time frame
Anti-tumor efficacy of genomically matched therapy in clinical practice, comparison with cancer-related databases in genomic mutation (including germline variants), and functional analysis	—

Countries

Japan

Contacts

Public ContactTakafumi Koyama

National Cancer Center Hospital Department of Experimental Therapeutics

takoyama@ncc.go.jp03-3542-2511

Outcome results